SEC Company Response from KAZIA THERAPEUTICS LTD (KZIA) (CIK 0001075880) (KZIA) — Jun 10, 2013
KAZIA THERAPEUTICS LTD (KZIA) (CIK 0001075880)
Date: June 10, 2013 · CIK: 0001075880 · Accession: 0001075880-13-000045
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 000-29962
Letter
Senior Assistant Chief Accountant United States Securities and Exchange Commission Washington DC 20549 BY EMAIL
Dear Mr Rosenberg,
Novogen Limited Form 20-F Year ended 30 June 2012
Filed October 29, 2012
File No. 000-29962
We refer to your correspondence dated March 29, 2013. As this matter is pending further
discussion, we request that you allow us ten more business days to consider our response.
Yours faithfully,
Steven Coffey
Director
Ref: 469074
Show Raw Text
CORRESP 1 filename1.htm Converted by EDGARwiz 10 June 2013 Mr J B Rosenberg Senior Assistant Chief Accountant United States Securities and Exchange Commission Washington DC 20549 BY EMAIL Dear Mr Rosenberg, Novogen Limited Form 20-F Year ended 30 June 2012 Filed October 29, 2012 File No. 000-29962 We refer to your correspondence dated March 29, 2013. As this matter is pending further discussion, we request that you allow us ten more business days to consider our response. Yours faithfully, Steven Coffey Director Ref: 469074